Latest News and Press Releases
Want to stay updated on the latest news?
-
Cutting-edge CAR-Treg technology could have broad application across common and rare neurodegenerative diseases Smith Founder and CEO Philip Ashton-Rickardt, Ph.D. joins as SVP of Immunology ...
-
BOSTON, Oct. 17, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced the closing of a $26.3 million Series C...
-
BOSTON, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced that investor, former...
-
First-in-class candidate targets microglia to slow or halt neuroinflammation and disease progression ALZT-OP1 trial being conducted under an SPA with expected completion in late 2020 BOSTON, Aug. ...
-
BOSTON, July 10, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced the hiring of Jay Mohr as Chief Operating...
-
Presentation to highlight Company’s late-stage clinical program and unique approach to neuroinflammation and the treatment of early Alzheimer’s disease BOSTON, June 26, 2019 (GLOBE NEWSWIRE) --...